Innoveren Scientific Inc. (IVRN)
OTCMKTS: IVRN · Delayed Price · USD
0.0040
+0.0004 (11.11%)
Jul 26, 2024, 1:40 PM EDT - Market closed
Innoveren Scientific Employees
Innoveren Scientific had 2 employees as of December 31, 2022. The number of employees decreased by 6 or -75.00% compared to the previous year.
Employees
2
Change (1Y)
-6
Growth (1Y)
-75.00%
Revenue / Employee
$807,455
Profits / Employee
-$3,641,708
Market Cap
18.22K
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 2 | -6 | -75.00% |
| Dec 31, 2021 | 8 | -18 | -69.23% |
| Dec 31, 2020 | 26 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 89,900 |
| Novartis AG | 76,057 |
| Merck & Co. | 72,000 |
| Novo Nordisk | 64,319 |
IVRN News
- 5 months ago - Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite - Accesswire
- 10 months ago - Innoveren Scientific Divests Device & Receives Capital Infusion - Accesswire
- 1 year ago - H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC - GlobeNewsWire
- 2 years ago - H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days - GlobeNewsWire
- 2 years ago - H-CYTE Completes Acquisition of Jantibody - GlobeNewsWire
- 2 years ago - H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days - GlobeNewsWire
- 2 years ago - H-CYTE Announces 1-for-1,000 Reverse Stock Split - GlobeNewsWire
- 2 years ago - H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise - GlobeNewsWire